758 High-potency synthetic STING agonists rewire the myeloid stroma in the tumour microenvironment to amplify immune checkpoint blockade efficacy in refractory pancreatic ductal adenocarcinoma

Boda, A., Ager, C., Rajapakshe, K., Lea, S., Francesco, M. E. D., Jones, P., & Curran, M. (2021). 758 High-potency synthetic STING agonists rewire the myeloid stroma in the tumour microenvironment to amplify immune checkpoint blockade efficacy in refractory pancreatic ductal adenocarcinoma. Regular and Young Investigator Award Abstracts, A793–A793. https://doi.org/10.1136/jitc-2021-sitc2021.758
Authors:
Akash R. Boda
Casey R. Ager
Kimal Rajapakshe
Spencer Lea
Maria Emilia Di Francesco
Philip Jones
Michael A. Curran
Affiliated Authors:
Casey R. Ager
Subjects:
Macrophage Activation and Polarization (OpenAlex Topic)
Cancer Immunotherapy (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1136/jitc-2021-sitc2021.758
DOI:
10.1136/jitc-2021-sitc2021.758
Journal:
Journal for ImmunoTherapy of Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: